Hongkong Winhealth Pharma Group
PrivateLast Round
Series B
Oct 1, 2025
Total Funding Raised
$189.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hongkong Winhealth Pharma Group is a biopharmaceutical company that focuses on the development, registration, and commercialization of innovative therapies for rare diseases and other critical medical conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Compliance, Patient Engagement
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hongkong Winhealth Pharma Group Comparables
Compare Hongkong Winhealth Pharma Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sperogenix Therapeutics | 80% | |
| Golden Age Health | 80% | |
| CANbridge Pharma | 78% |
Hongkong Winhealth Pharma Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 1, 2025 | ||||
| Series A | Apr 1, 2019 | ||||
| Corporate Funding | Aug 15, 2018 |
Key People
Founding team and executive leadership
Hongkong Winhealth Pharma Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TD Capital Management LLC | Series B |
| Kaitai Capital | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 58% MoM.
- Mar 3, 2026
Monthly visitors grew 50% MoM.
Hongkong Winhealth Pharma Group Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hongkong Winhealth Pharma Group's valuation, stock price, and market status.
Is Hongkong Winhealth Pharma Group a public or private company?
Hongkong Winhealth Pharma Group is a private company.
What is the current stock price of Hongkong Winhealth Pharma Group?
Hongkong Winhealth Pharma Group is a private company with no public stock price. No recent secondary market data is available.
How much is Hongkong Winhealth Pharma Group worth (valuation)?
Valuation information for Hongkong Winhealth Pharma Group is not publicly available.
Can I buy Hongkong Winhealth Pharma Group stock?
Hongkong Winhealth Pharma Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hongkong Winhealth Pharma Group's last funding round?
Hongkong Winhealth Pharma Group's most recent funding round was Series B on October 1, 2025.
Who are the main investors in Hongkong Winhealth Pharma Group?
Key investors in Hongkong Winhealth Pharma Group include TD Capital Management LLC, Kaitai Capital.
Will Hongkong Winhealth Pharma Group IPO soon?
No public IPO plans have been announced for Hongkong Winhealth Pharma Group.
How can I track Hongkong Winhealth Pharma Group secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hongkong Winhealth Pharma Group's secondary market activity and sign up for updates.